Cargando…
Too Much Compromise in Today's CRISPR Pipelines
CRISPR-based editing is a revolutionary tool for genome engineering and discovery. The pace of innovation in this young field is truly astonishing, and yet significant gaps remain in the set of capabilities offered. In particular, scalable (massively parallel and multiplex) editing is only available...
Autor principal: | Fox, Richard |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Mary Ann Liebert, Inc., publishers
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6694770/ https://www.ncbi.nlm.nih.gov/pubmed/31225751 http://dx.doi.org/10.1089/crispr.2019.0015 |
Ejemplares similares
-
Too Much, Too Mild, Too Early: Diagnosing the Excessive Expansion of Diagnoses
por: Hofmann, Bjørn
Publicado: (2022) -
Fresh from the biotech pipeline: too much, too fast?
por: Senior, Melanie
Publicado: (2022) -
“Too much, too late”: data on stillbirths to improve interpretation of caesarean section rates
por: Zethof, Siem, et al.
Publicado: (2022) -
Too Much Cleavage of Cyclin E Promotes Breast Tumorigenesis
por: Loeb, Keith R., et al.
Publicado: (2012) -
It's All in the Timing: Too Much E2F Is a Bad Thing
por: Nicolay, Brandon N., et al.
Publicado: (2012)